Life-cycle management of a Swiss marketing authorisation: variations explained
Getting a medicine approved is only the beginning. Over its life on the market, almost everything about a product can change: the manufacturing site, a supplier, the packaging, the shelf life, the indications, and the safety information.
Moving from Romanian to Swiss pharmacy practice: what MEBEKO recognition taught me about regulation
My career as a pharmacist has crossed three healthcare systems: Romania, Moldova and Switzerland. Each move required me to learn a new set of rules, institutions and expectations. The common thread is that regulation is not an obstacle to practice; it is the shared language that makes safe practice
Swiss vs EU pharmacovigilance: what's the same, what's different
Switzerland sits in the middle of Europe but outside the European Union. For pharmacovigilance, that creates a system that looks familiar to anyone trained on EU rules, yet has its own authority, its own reporting routes and its own local obligations.
A pharmacist's guide to the Swiss therapeutic products framework
Swiss medicines law can look like an alphabet soup: HMG, VAM, AMBV, AMZV, KlinV. Behind the abbreviations is a clear structure. One federal act sets the principles, and a set of ordinances spells out the detail for each part of a medicine's life.